4-butyrolactone has been researched along with Equine Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bauck, AG; Gilliam, LL; Kembel, SL; Schoonover, MJ; Taylor, JD; Young, JM | 1 |
| Benson, SM; Berghaus, LJ; Berghaus, RD; Burden, CA; Giguère, S; Hart, KA; Hayna, JT; Horohov, DW; Kelleman, AA; Lyle, SK; Macpherson, ML; Mallicote, MF; Pozor, MA; Randell, SA; Varner, JC | 1 |
| Blikslager, A; Fogle, C; Ziegler, A | 1 |
| Fortier, LA; Goodale, MB; Maylin, GA; Ober, C; Ortved, KF | 1 |
| Chamoun-Emanuelli, AM; Cohen, ND; Dockery, HJ; Richardson, LM; Whitfield-Cargile, CM | 1 |
| Blikslager, AT; Burke, MJ; Cook, VL; Davis, JL; Fogle, CA; Freeman, CK; Southwood, LL; Ziegler, AL | 1 |
| Alvarenga, MA; Correal, SB; Cyrino, M; Dell'Aqua, JA; Freitas-Dell'Aqua, CP; Friso, AM; Miró, J; Papa, FO; Segabinazzi, LGTM; Teoro do Carmo, M | 1 |
| Kivett, L; Taintor, J; Wright, J | 1 |
| Back, W; Hanson, PD; MacAllister, CG; Pollmeier, M; van Heel, MC | 1 |
| Blikslager, AT; Campbell, NB; Cook, VL; Meyer, CT | 1 |
| Boston, RC; Carithers, DS; Orsini, JA; Ryan, WG | 1 |
| Alva, R; Bertone, AL; Doucet, MY; Hanson, PD; Hendrickson, D; Hughes, F; Kunkle, B; Macallister, C; McClure, S; Reinemeyer, C; Romano, D; Rossier, Y; Sifferman, R; Vrins, AA; White, G | 1 |
1 review(s) available for 4-butyrolactone and Equine Diseases
| Article | Year |
|---|---|
Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Drug Compounding; Horse Diseases; Horses; Species Specificity; Sulfones; Veterinary Drugs | 2017 |
6 trial(s) available for 4-butyrolactone and Equine Diseases
| Article | Year |
|---|---|
Efficacy of orally administered gabapentin in horses with chronic thoracic limb lameness.
Topics: 4-Butyrolactone; Analgesics; Animals; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Gabapentin; Horse Diseases; Horses; Lameness, Animal; Male; Sulfones | 2020 |
Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Female; Horse Diseases; Horses; Intestinal Obstruction; Male; Pain, Postoperative; Random Allocation; Sulfones | 2019 |
Periovulatory administration of firocoxib did not alter ovulation rates and mitigated post-breeding inflammatory response in mares.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Breeding; Cross-Over Studies; Drug Administration Schedule; Endometritis; Estrous Cycle; Female; Horse Diseases; Horses; Inflammation; Insemination, Artificial; Male; Ovulation; Pregnancy; Pregnancy Rate; Sulfones; Treatment Outcome | 2019 |
The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Female; Forelimb; Horse Diseases; Horses; Lameness, Animal; Male; Pressure; Sulfones | 2009 |
Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Cyclooxygenase 2 Inhibitors; Female; Horse Diseases; Horses; Lameness, Animal; Male; Musculoskeletal Pain; Osteoarthritis; Pain Management; Sulfones | 2012 |
Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Horse Diseases; Horses; Lameness, Animal; Male; Osteoarthritis; Phenylbutazone; Range of Motion, Articular; Severity of Illness Index; Sulfones; Time Factors; Treatment Outcome | 2008 |
5 other study(ies) available for 4-butyrolactone and Equine Diseases
| Article | Year |
|---|---|
Evidence for anti-inflammatory effects of firocoxib administered to mares with experimentally induced placentitis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2 Inhibitors; Female; Horse Diseases; Horses; Inflammation; Interleukin-6; Matrix Metalloproteinase 1; Placenta; Placenta Diseases; Pregnancy; Prostaglandins; Sulfones; Tumor Necrosis Factor-alpha | 2021 |
Plasma firocoxib concentrations after intra-articular injection of autologous conditioned serum prepared from firocoxib positive horses.
Topics: 4-Butyrolactone; Animals; Blood Transfusion, Autologous; Cyclooxygenase 2 Inhibitors; Female; Horse Diseases; Horses; Injections, Intra-Articular; Joint Diseases; Limit of Detection; Male; Sulfones | 2017 |
Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Feces; Gastrointestinal Diseases; Horse Diseases; Horses; Inflammation; Peroxidase; Phenylbutazone; Random Allocation; Stomach Ulcer; Sulfones | 2018 |
Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Creatinine; Drug Therapy, Combination; Horse Diseases; Horses; Kidney Diseases; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Sulfones | 2014 |
Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
Topics: 4-Butyrolactone; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Eicosanoids; Electrophoresis, Polyacrylamide Gel; Horse Diseases; Horses; Ischemia; Jejunal Diseases; Sulfones; Thromboxane B2 | 2009 |